Upgrade to SI Premium - Free Trial

AlloVir (ALVR)

9.81 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/1/25 *Est.)

Latest Headlines

Form 4 Kalaris Therapeutics, For: Aug 27 Filed by: Vandekop Amy O'Leary August 28, 2026 4:11 PM - SEC Filing Form 10-Q Kalaris Therapeutics, For: Jun 30 August 11, 2026 4:02 PM - SEC Filing Form 8-K Kalaris Therapeutics, For: Aug 11 August 11, 2026 8:06 AM - SEC Filing Form 4 Kalaris Therapeutics, For: Aug 01 Filed by: KEATING LAURIE August 3, 2026 4:06 PM - SEC Filing Form 3 Kalaris Therapeutics, For: Aug 01 Filed by: KEATING LAURIE August 3, 2026 4:02 PM - SEC Filing Form 3 Kalaris Therapeutics, For: Jul 27 Filed by: Vandekop Amy O'Leary July 27, 2026 4:05 PM - SEC Filing Full Article List